In this review, single-chain fragment variable construction using phage-display technology as a promising anticancer immunotherapy technology is described. Cloning and the specific bio-panning selection with phage display technology, as well as the use of the epidermal growth factor receptor (EGFR) at the surface of MCF-7 cells as the antigen for the straightforward specific selection of single chain Fvs, are discussed. Moreover, phage display technologies and their application are important for vaccine production and immunotherapy against viruses and cancers. Furthermore, expression of the gene will cause the production and expression of the protein in prokaryotic and eukaryotic cells, which can be used to detect anti-cancer single chain fragment variables (scFvs). Finally, homology modelling is described to show the three-dimensional scFv structure that verifies the Complementary-Determining-Regions (CDRs) on the surface of the model.
References
[1]
Howell, A., DeFriend, D. and Anderson, E. (1993) Mechanisms of Response and Resistance to Endocrine Therapy for Breast Cancer and the Development of New Treatments. Reviews on Endocrine-Related Cancer, 43, 5-21.
[2]
Kuan, C.T., Wikstrand, C.J. and Bigner, D.D. (2001) EGF Mutant Receptor vIII as a Molecular Target in Cancer Therapy. Endocrine-Related Cancer, 8, 83-96. https://doi.org/10.1677/erc.0.0080083
[3]
Tang, C.K., Gong, X.Q., Moscatello, D.K., Wong, A.J. and Lippman, M.E. (2000) Epidermal Growth Factor Receptor vIII Enhances Tumorigenicity in Human Breast Cancer. Cancer Research, 60, 3081-308.
[4]
Wikstrand, C.J, McLendon, R.E., Friedman, A.H. and Bigner, D.D. (1997) Cell Surface Localization and Density of the Tumor-Associated Variant of the Epidermal Growth Factor Receptor, EGFRvIII. Cancer Research, 57, 4130-4140.
[5]
Reist, C.J., Batra, S.W., Pegram, C.N., Bigner, D.D. and Zalutsky, M.R. (1997) In Vitro and in Vivo Behavior of Radiolabeled Chimeric Anti-EGFRvIII Monoclonal Antibody: Comparison with Its Murine Parent. Nuclear Medicine and Biology, 24, 637-647. https://doi.org/10.1016/S0969-8051(97)00080-2
[6]
Spiegelberg, H.L. (1974) Biological Activities of Immunoglobulins of Different Classes and Subclasses. Advances in Immunology, 19, 259-294.
[7]
Sivasubramanian, A., Sircar, A., Chaudhury, S. and Gray, J.J. (2009) Toward High-Resolution Homology Modeling of Antibody Fv Regions and Application to Antibody-Antigen Docking. Proteins, 74, 497-514. https://doi.org/10.1002/prot.22309
[8]
Cohen-Solal, J.F.G., Cassard, L., Fridman, W. and Sautès-Fridman, C. (2004) Fc Gamma Receptors. Immunology Letters, 92, 199-205.
[9]
Lesk, A.M. and Chothia, C. (1982) Evolution of Proteins Formed by Beta-Sheets. II. The Core of the Immunoglobulin Domains. Journal of Molecular Biology, 160, 325-342.
[10]
Brambell, F.W., Hemmings, W.A. and Morris, I.G.A. (1964) Theoretical Model of Gamma-Globulin Catabolism. Nature, 203, 1352-1354. https://doi.org/10.1038/2031352a0
[11]
Verma, R., Boleti, E. and George, A.J.T. (1998) Antibody Engineering: comparison of Bacterial, Yeast, Insect and Mammalian Expression Systems. Journal of Immunological Methods, 216, 165-181.
[12]
Pluckthun, A., et al. (1996) Producing Antibodies in Escherichia coli: From PCR to Fermentation. In: McCafferty, J., Hoogenboom, H.R. and Chiswell, D.J., Eds., Antibody Engineering: A Practical Approach, IRL Press, Oxford, 203-252.
[13]
Roopenian, D.C. and Akilesh, S. (2007) FcRn: The Neonatal Fc Receptor Comes of Age. Nature Reviews Immunology, 7, 715-725.
[14]
Shimada, N., Suzuki, Y., Nakajima, M., Conrad, U., Murofushi, N. and Yamaguchi, I. (1999) Expression of a Functional Single Chain Antibody against GA24/19 in Transgenic Tobacco. Bioscience, Biotechnology, and Biochemistry, 63, 779-783. https://doi.org/10.1271/bbb.63.779
[15]
Elham, M.O. and Bolad, A.K. (2014) Construction and Expression of Single-Chain Variable Fragment (ScFv) against MCF7 Breast Cancer Cells by Phage Display Technology. Journal of Cancer Research and Therapeutics, 10, 265.
[16]
Reiter, Y., Brinkmann, U., Webber, K.O., Jung, S.-H., Lee, B. and Pastan, I. (1994) Engineering Interchain Disulfide Bonds into Conserved Framework Regions of Fv Fragments: Improved Biochemical Characteristics of Recombinant Immunotoxins Containing Disulfide-Stabilized Fv. Protein Engineering, 7, 667-704. https://doi.org/10.1093/protein/7.5.697
[17]
Chua, K.H. (2003) Bioinformatics in Molecular Immunology Laboratories Emonstrated Modeling an Anti-CMV scFv Antibody. Asia-Pacific Journal of Molecular Biology and Biotechnology, 11, 93-96.
[18]
Mahgoub, E.O. and Bolad, A. (2013) Correctness and Accuracy of Template-Based Modeled Single Chain Fragment Variable (scFv) Protein Anti-Breast Cancer Cell Line (MCF-7). Open Journal of Genetics, 3, 183-194. https://doi.org/10.4236/ojgen.2013.33021
[19]
Douglas, J.T. and Curiel, D.T. (1997) Strategies to Accomplish Targeted Gene Delivery to Muscle Cells Employing Tropism-Modified Adenoviral Vectors. Neuromuscular Disorders, 7, 284-298. https://doi.org/10.1016/S0960-8966(97)00053-9
[20]
Nejatollahi, F., Hodgetts, S.J., Vallely, P.J. and Burnie, J.P. (2002) Neutralizing Human Recombinant Antibodies to Human Cytomegalovirus Glycoproteins gB and gH. FEMS Immunology and Medical Microbiology, 34, 237-244. https://doi.org/10.1111/j.1574-695X.2002.tb00630.x
[21]
Hudson, P.J. and Souriau, C. (2001) Recombinant Antibodies for Cancer Diagnosis and Therapy. Expert Opinion on Biological Therapy, 1, 845-855. https://doi.org/10.1517/14712598.1.5.845
[22]
Pai, L.H. and Pastan, I. (1998) Clinical Trials with Pseudomonas Exotoxin Immunotoxins. In: Frankel, A.E., Ed., Clinical Applications of Immunotoxins, Springer, Berlin, Heidelberg, 83-96. https://doi.org/10.1007/978-3-642-72153-3_6
[23]
Liu, S.Y., Eary, J.F., Petersdorf, S.H., Martin, P.J., Maloney, D.G., Appelbaum, F.R., Matthews, D.C., Bush, S.A., Durack, L.D., Fisher, D.R., Gooley, T.A., Bernstein, I.D. and Press, O.W. (1998) Follow-Up of Relapsed B-Cell Lymphoma Patients Treated with Iodine-131-Labeled Anti-CD20 Antibody and Autologous Stem-Cell Rescue. Journal of Clinical Oncology, 16, 3270-3278. https://doi.org/10.1200/JCO.1998.16.10.3270
[24]
Chari, R.V. (1998) Targeted Delivery of Chemotherapeutics: Tumor-Activated Prodrug Therapy. Advanced Drug Delivery Reviews, 31, 89-104.
[25]
Gunter, M., Harder, S., Sascha, H., Jager, E., Al-Batran, S., Sibylle, L., Atmaca, A., Cimpoiasu, C., Neumann, A., Abera, A., Knuth, A., Kaufmann, M., Dirk, J., Alexander, B. and Maurer, W.S. (2005) Clinical Study of the Recombinant Antibody Toxin scFv(FRP5)-ETA Specific for the ErbB2/HER2 Receptor in Patients with Advanced Solid Malignomas. Breast Cancer Research, 7, R617-R626. https://doi.org/10.1186/bcr1264
[26]
Mahgoub, I.O. (2012) Expression and Characterization of a Functional Single-Chain Variable Fragment (scFv) Protein Recognizing MCF7 Breast Cancer Cells in E. coli Cytoplasm. Biochemical Genetics, 50, 625-641. https://doi.org/10.1007/s10528-012-9506-4
[27]
Griep, R.A., Prins, M., Van Twisk, C., Keller, H.J.H.G., Kerschbaumer, R.J., Kormelink, R., Goldbach, R.W. and Schots, A. (2000) Application of Phage Display in Selecting Tomato Spotted Wilt Virus-Specific Single-Chain Antibodies (scFvs) for Sensitive Diagnosis In ELISA. Phytopathology, 90, 183-190. https://doi.org/10.1094/PHYTO.2000.90.2.183
[28]
Berek, C. and Milstein, C. (1988) The Dynamic Nature of the Antibody Repertoire. Immunological Reviews, 105, 5-26. https://doi.org/10.1111/j.1600-065X.1988.tb00763.x
[29]
Smith, G.P. (1985) Filamentous Fusion Phage: Novel Expression Vectors That Display Cloned Antigens on the Virion Surface. Science, 228, 1315-1317. https://doi.org/10.1126/science.4001944
[30]
Sparks, A.B., Ade, N.B., Cwirla, S., Kay, B.K., Winter, J. and McCafferty, J. (1996) Screening Phage-Displayed Random Peptide Libraries. In: Phage Display of Peptides and Proteins, Academic Press, Cambridge, MA, 227-253.
[31]
McCafferty, J. and Johnson, K.S. (1996) Construction and Screening of Antibody Display Libraries. In: Kay, B.K., Winter, J. and McCafferty, J., Eds., Phage Display of Peptides and Proteins, Academic Press, Cambridge, MA, 79-111.
[32]
Whaley, S.R., English, D.S., Hu, E.L., Barbara, P.F. and Belcher, A.M. (2000) Selection of Peptides with Semiconductor Binding Specificity for Directed Nanocrystal Assembly. Nature, 405, 665-668. https://doi.org/10.1038/35015043
[33]
Chowdhury, P.S., Viner, J.L., Beers, R. and Pastan, I. (1998) Isolation of a High-Affinity Stable Single-Chain Fv Specific for Mesothelin from DNA-Immunized Mice by Phage Display and Construction of a Recombinant Immunotoxin with Anti-Tumor Activity. Proceedings of the National Academy of Sciences of the United States of America, 95, 669-674. https://doi.org/10.1073/pnas.95.2.669
[34]
Chester, K.A., Begent, R.H., Robson, L., Keep, P., Pedley, R.B., Boden, J.A., Boxer, G., Green, A., Winter, G. and Cochet, O. (1994) Phage Libraries for Generation of Clinically Useful Antibodies. The Lancet, 343, 455-456. https://doi.org/10.1016/S0140-6736(94)92695-6
[35]
Barbas, C.F, Burton, D.R. and Silverman, G.J. (2004) Phage Display: A Laboratory Manual. Cold Spring Harbor Laboratory Press.
[36]
Vaughan, T.J., Williams, A.J., Pritchard, K., Osbourn, J.K., Pope, A.R., Earnshaw, J.C., McCafferty, J., Hodits, R.A., Wilton, J. and Johnson, K.S. (1996) Human Antibodies with Sub-Nanomolar Affinities Isolated from a Large Non-Immunized Phage Display Library. Nature Biotechnology, 14, 309-314. https://doi.org/10.1038/nbt0396-309
[37]
Ellman, J.A. and Gallop, M.A. (1998) Combinational Chemistry. Current Opinion in Chemical Biology, 2, 317-319.
[38]
Hoogenboom, H.R. and Chames, P. (2000) Natural and Designer Binding Sites Made by Phage Display Technology. Immunology Today, 21, 371-378. https://doi.org/10.1016/S0167-5699(00)01667-4
[39]
Hoogenboom, H.R., de Bruïne, A.P., Hufton, S.E., Hoet, R.M., Arends, J.W. and Roovers, R.C. (1998) Antibody Phage Display and Its Applications. Immunotechnology, 4, 1-20.
[40]
Low, N.M., Holliger, P. and Winter, G. (1996) Mimicking Somatic Hypermutation: Affinity Maturation of Antibodies Displayed on Bacteriophage Using Bacterial Mutator Strain. Journal of Molecular Biology, 260, 359-368.
[41]
Clackson, T., Hoogenboom, H.R., Griffiths, A.D. and Winker, G. (1991) Making Antibody Fragments Using Phage Display Libraries. Nature, 352, 624-628. https://doi.org/10.1038/352624a0
[42]
Marks, J.D., Griffiths, A.D., Malmqvist, M., Clackson, T.P., Bye, J.M. and Winter, G. (1992) Bypassing Immunization: Building High Affinity Human Antibodies by Chain Shuffling. Biotechnology, 10, 779-783.
[43]
Stemmer, W.P. (1994) Rapid Evolution of a Protein in Vitro by DNA Shuffling. Nature, 370, 389-391. https://doi.org/10.1038/370389a0
Ritz, D., Lim, J., Reynolds, C.M., Poole, L.B. and Beckwith, J. (2001) Conversion of a Peroxiredoxin into a Disulfide Reductase by a Triplet Repeat Expansion. Science, 294, 158-160. https://doi.org/10.1126/science.1063143
[46]
LaVallie, E.R., et al. (1993) A Thioredoxin Gene Fusion Expression System that Circumvents Inclusion Body Formation in the E. Coli Cytoplasm. Nature Biotechnology, 11, 187-193.
[47]
Chames, P. and Baty, D. (2000) Antibody Engineering and Its Applications in Tumor Targeting and Intracellular Immunization. FEMS Microbiology Letters, 189, 1-8. https://doi.org/10.1111/j.1574-6968.2000.tb09197.x
[48]
Blundell, T.L., Sibanda, B.L., Sternberg, M.J. and Thornton, J.M. (1987) Knowledge-Based Prediction of Protein Structures and the Design of Novel Molecules. Nature, 326, 347-352. https://doi.org/10.1038/326347a0
[49]
Greer, J. (1981) Comparative Model-Building of the Mammalian Serine Proteases. Journal of Molecular Biology, 153, 1027-1042.
[50]
Johnson, M.S., Srinivasan, N., Sowdhamini, R. and Blundell, T.L. (1994) Knowledge-Based Protein Modelling. Critical Reviews in Biochemistry and Molecular Biology, 29, 1-68. https://doi.org/10.3109/10409239409086797
[51]
Sali, A. and Blundell, T.L. (1993) Comparative Protein Modelling by Satisfaction of Spatial Restraints. Journal of Molecular Biology, 234, 779-815.
[52]
Sali, A. (1995) Modeling Mutations and Homologous Proteins. Current Opinion in Biotechnology, 6, 437-451.
[53]
Sanchez, R., Pieper, U., Melo, F., Eswar, N., Marti-Renom, M.A., Madhusudhan, M.S., Mirkovic, N. and Sali, A. (2000) Protein Structure Modeling for Structural Genomics. Nature Structural & Molecular Biology, 7, 986-990. https://doi.org/10.1038/80776
[54]
Deng, X.K., Nesbit, L.A. and Morrow Jr., K.J. (2003) Recombinant Single-Chain Variable Fragment Antibodies Directed against Clostridium difficile Toxin B Produced by Use of an Optimized Phage Display System. Clinical and Diagnostic Laboratory Immunology, 10, 587-595.
[55]
Marti-Renom, M.A., Stuart, A.C., Fiser, A., Sanchez, R., Melo, F. and Sali, A. (2000) Comparative Protein Structure Modeling of Genes and Genomes. Annual Review of Biophysics and Biomolecular Structure, 29, 291-325. https://doi.org/10.1146/annurev.biophys.29.1.291
[56]
Fiser, A., Do, R.K. and Sali, A. (2000) Modeling of Loops in Protein Structures. Protein Science, 9, 1753-1773. https://doi.org/10.1110/ps.9.9.1753
